The calcium-sensing receptor (CaSR) is a Family C G protein-coupled receptor that is activated by elevated levels of extracellular divalent cations.
The CaSR couples to members of the Gq family of G-proteins and in the endocrine system this receptor is instrumental in regulating the release of parathyroid hormone from the parathyroid gland and calcitonin from thyroid cells. Here, we demonstrate that in medullary thyroid carcinoma cells, the CaSR promotes cellular adhesion and migration via coupling to members of the integrin family of extracellular matrix binding proteins. Immunopurification and mass spectrometry, coimmunoprecipitation, and co-localization studies showed that the CaSR and β1-containing integrins are components of a macromolecular protein complex.
In fibronectin-based cell adhesion and migration assays, the CaSR positive allosteric modulator NPS R-568 induced a concentration-dependent increase in cell adhesion and migration; both of these effects were blocked by a specific CaSR negative allosteric modulator. These effects were mediated by integrins because they were blocked by a peptide inhibitor of integrin binding to fibronectin, and β1 knock down experiments.
An analysis of intracellular signalling pathways revealed a key role for CaSR-induced phospholipase C activation and the release of intracellular calcium. These results demonstrate for the first time that an ion-sensing G protein-coupled receptor functionally couples to the integrins, and in conjunction with intracellular calcium release, promotes cellular adhesion and migration in tumour cells.
The significance of this interaction is further highlighted by studies implicating the CaSR in cancer metastasis, axonal growth, and stem-cell attachment, functions that rely on integrin-mediated cell adhesion.
The calcium-sensing receptor (CaSR) 2 is a widely expressed homodimeric G protein-coupled receptor (GPCR) that functions as a multi-modal nutrient sensor to maintain systemic calcium (Ca 2+ ) homeostasis by sensing changes in extracellular Ca 2+ concentrations. This receptor belongs to a subset of GPCRs (Class C) that includes the metabotropic glutamate receptors, the GABA B receptor, and GPRC6A (1) . The CaSR regulates the blood-mineral ion balance largely by regulating parathyroid hormone secretion by the parathyroid gland, calcitonin secretion by the thyroid gland, Ca 2+ excretion by the kidneys, and osteoblast proliferation and differentiation (2) (3) (4) .
In addition to activation by Ca 2+ ions, the CaSR is also activated or potentiated by a variety of compounds including other di-and trivalent cations, polyamines such as spermine, aminoglycosides, as well as other physiologically relevant molecules including L-amino acids and γ-glutamyl peptides (including glutathione), and pharmacologically important phenylalkylamine calcimimetics such as Cinacalcet and NPS R-568 (1, (5) (6) (7) (8) .
The widespread expression of the CaSR in tissues with functions unrelated to plasma Ca 2+ regulation suggests that the CaSR regulates a variety of processes independent of systemic Ca 2+ homeostasis. In the nervous system for example, the CaSR has been shown to mediate axonal growth and neuronal branching (9) , and promote spontaneous release of glutamate from nerve terminals (10) . CaSR stimulation also induces plasma membrane ruffling (11) and inhibition of CaSR function in stem cells results in defective target localization (11) (12) (13) .
A role for the CaSR in cell adherence is also supported by studies conducted on haematopoietic stem cells. During fetal development, stem cells from fetal liver migrate to the endosteal surfaces of the bone marrow cavity to undergo haematopoiesis (14) .
Several studies have demonstrated that the endosteal surface provides a niche for CaSR expressing haematopoietic stem cells to preferentially localize to the bone, and that haematopoietic stem cells prepared from mice lacking the CaSR were defective in localizing to the endosteal niche due to defective adhesion to the extracellular matrix protein, type I collagen (12, 13) . Finally, a potential role of the CaSR in tumour metastasis is suggested by studies showing the expression of the CaSR in prostate and breast cancer cells that preferentially metastasize to bone (15, 16) , and that the elevated Ca 2+ concentrations detected by the CaSR on highly metastatic, bonepreferring cancer cells have been shown to provide a strong chemo-attractant factor for cancer cell metastasis to bone cells (15, 17) .
Despite a large cohort of studies on CaSR function, the signaling partners and protein-protein interactions of the CaSR mediating these effects have not been well characterized. To address this gap, we investigated the signaling proteins and underlying mechanisms involved in CaSRmediated cell adhesion and migration in rat medullary thyroid carcinoma cells (rMTC 44-2). These metastatic neuroendocrine cells, which endogenously express the CaSR, possess both neuronal and cancerous characteristics (18, 19) , and therefore have the potential to serve as a suitable model system to delineate CaSR proteinprotein interactions involved in cell adhesion and/or migration.
In initial immunopurification and proteomic analysis experiments of the CaSR, we discovered that the CaSR and β1-containing integrins are present in a macromolecular protein complex in rMTC 44-2 cells. Integrins, which are obligate heterodimers composed of α and β subunits, bind to extracellular matrix (ECM) binding proteins and function as adhesion proteins that provide cells with a functional link between the intracellular cytoskeleton and the extracellular environment (20, 21) . Further analyses using the ECM protein fibronectin in cell adhesion and migration assays revealed that a CaSR-selective positive allosteric positive modulator (NPS R-568) potentiated integrin-mediated cell attachment and migration towards a fibronectin matrix, and that both processes are dependent on activation of phospholipase C (PLC) and release in intracellular calcium ( rMTC cells grown to 80-90% confluency on ten 150 x 25 mm dishes were isolated and lysed in 10 ml 50 mM Tris-HCl (pH 7.4) using a Polytron (setting 6, 5 seconds), followed by centrifugation for 20 min at 48,000 X g. The supernatant was removed and the pellet was resuspended in 5 ml 50 mM Tris-HCl (pH 7.4). An aliquot of the suspension was used to determine the protein concentration using the Quanti-Pro BCA kit (Sigma) while the remaining suspension was centrifuged for 20 min at 48,000 X g. The supernatant was discarded and the pellet was resuspended in solubilization buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM NaH 2 PO 4 -7H 2 O, 10 mM CaCl 2 and 1% Triton X-100, pH 7.5) at a protein concentration of 3 mg/ml. In some experiments (see Results section), the membranes were solublized with 0.5% CHAPS or 0.5% deoxycholate + 0.1% SDS. The suspension was incubated at 4 0 C rocking for 1 h, followed by centrifugation for 1 h at 48,000 X g. The supernatant containing the solubilized proteins was collected and aliquoted into 1 ml fractions.
The general procedure for immunoprecipitation was conducted as described previously (22) . Briefly, the solubilized samples were precleared with 50 μl of 50% Protein A and Protein G slurry (1:1 bead slurry; BioShop) per 1 ml aliquot and incubated for 1 h at 4 0 C rocking. The samples were centrifuged at 2,000 x g for 2 min, and the pre-cleared supernatant was transferred to a new microcentrifuge tube with 1 μg of anti-CaSR ADD mouse monoclonal antibody (Thermo Scientific Inc.Cat. # MA1-934), 2 μg of anti-CaSR 4640 rabbit polyclonal antibody, or 2 μg of anti-CaSR 4641 rabbit polyclonal antibody (generated in two different rabbits in house at NPS Pharmaceuticals to the ADD sequence: ADDDYGRPGIEKFREEAEE RDIC), or 2 μg of N-term β1 integrin rat monoclonal antibody (AIIB2, Hybridoma Bank), or 2 μg of β1 integrin C-terminal rabbit polyclonal antibody (Chemicon, AB1952) for 1 h at 4 0 C rocking. In parallel, Protein A + G beads were blocked with 1 mg/ml bovine serum mixture for 1 hr, washed and resuspended in equal volumes of wash buffer (20 mM Tris-HCl, 0.1% TX-100, 1% glycerol and 100 mM NaCl, pH 7.5). 50 μl of the precleared Protein A/G slurry were added to the antibody containing solubilized samples and incubated overnight at 4 0 C rocking. The Protein A/G beads were collected by centrifugation, washed three times in wash buffer, resuspended in 60 μl of 2X sample buffer (4% SDS, 62.5 mM Tris, and 10% glycerol, pH 6.8) and 100 mM DTT, and incubated at 37 0 C for 15 min. The resulting eluates were subjected to SDS-PAGE and western blotting. For detection of the CaSR, the western blots were probed with the CaSR ADD antibody, and for detection of the β1 integrin, the blots were probed with β1 integrin antibodies purchased from Cell Signaling (Cat. #4706). PNGase F was obtained from New England Biolabs and used according to the manufacture's instructions.
Mass Spectrometry Sample Preparation and
Protein Identification -The CaSR was immunopurified as described above with minor modifications. Briefly, 10 ml of the TX-100-solubilized membrane preparation was precleared with 500 μl of 50% Protein A/G slurry and incubated with 10 μg of the CaSR ADD antibody with 150 μl of Protein A/G overnight at 4 0 C rocking. The Protein A/G beads were collected, washed three times in wash buffer, then washed three times in 50 mM ammonium bicarbonate (pH 7.8) and eluted three times in 200 μl of ammonium hydroxide (pH 11.0) at 37 0 C for 15 min each. The combined eluates were dried in a SpeedVac (Thermo Scientific Inc.) and the proteins were resuspended in 50 mM ammonium bicarbonate, reduced in 25 mM dithiothreitol, alkylated with 100 mM iodoacetamide (Sigma), and supplemented with 1 mM CaCl 2 prior to digestion with 1 μg of sequenced-grade trypsin (Promega, V511) at 37 0 C overnight. The resulting peptide mixture was loaded onto a C-12 reverse-phase nano-column packed in-house in a pressure bomb, eluted from an HPLC using a 2 h gradient of buffer A (95% acetonitrile, 0.1% trifluoroacetic acid) and buffer B (95% acetonitrile, 5% water, 0.1% trifluoroacetic acid) and subjected to electrospray ionization followed by analysis on a LTQ-XL Linear Ion Trap Mass Spectrometer (Thermo Scientific). The acquired tandem mass spectra were searched against the rat NCBI sequences using a normalized implementation of the SEQUEST algorithm running on the Sorcerer platform. The resulting peptide sequences identified by SEQUEST were filtered and assembled into protein identifications using peptide and protein prophets (ISB, Seattle) (23) . Immunocytochemistry -rMTC cells were plated on poly-D-lysine-treated glass coverslips and grown for 3 days in normal culture media. On the day of experiment, the cells were fixed with 4% paraformaldehyde for 15 min, blocked for 30 min using 5% goat serum (non-permeabilized) and incubated with extracellular epitope binding antiCaSR ADD antibody (1:500) and rabbit anti-β1- 2+ assay buffer (20 mM HEPES, 146 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 0.5 mM CaCl 2 , 1mg/ml bovine serum albumin, and 1 mg/ml glucose; pH 7.4), loaded with 6 μM Ca 2+ sensitive fluorescent dye Fluo-4 AM (Invitrogen) and incubated in the dark for 1 h at room temperature (24, 25) . The cells were washed three times and incubated with 150 μl assay buffer for 30 min at room temperature in the dark. CaCl 2 and NPS 89636 dissolved in assay buffer were added at various time points and the resulting fluorescence measurements (R.F.U.) were made at room temperature on a FlexStation scanning fluorometer (Molecular Devices Inc.) at 485 nm excitation and 525 nm emission (515 nm cut-off). GraphPad Prism was used to plot the R.F.U. measurements and calculate the EC 50 and Hill slope values. All data represented correspond to means ± standard error of means (S.E.M.) from representative experiments performed in triplicate. ERK1/2 Phosphorylation Assay -Confluent rMTC cells grown on 12 well plates were serum starved overnight in DMEM:F12 (1:1), and preincubated for 3 h with ERK assay buffer (20 mM HEPES, 146 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mg/ml bovine serum albumin, and 1 mg/ml glucose; pH 7.4 ) containing 1.8 mM Ca 2+ . The cells were then exposed to 0.003% DMSO or 1 μM R-586 for 5 min at 37 0 C in the presence and absence of 50 μM PD 98059. Reactions were terminated with icecold PBS and the cells were lysed using ERK lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM NaF, 50 mM β-glycerophosphate, 0.25 mM Naorthovanadate, 500nM okadaic acid, 1% TX-100, 0.5% Na-deoxycholate, 0.1% SDS). The contents of the wells were recovered, solubilized for 10 min at 4 0 C rocking, and spun at 21,000 X g for 10 min. The supernatant was isolated and the protein concentration was quantified using the QuantiPro BCA kit. 8 μg equivalents of each protein sample were subjected to SDS-PAGE and Western blotting. Anti-ERK1/2 antibody (1:2000) (Cell Signaling; #4370) was used for the detection of phosphorylated ERK1/2, and anti-GAPDH antibody (1:80000) (Sigma; G3895) was used as an internal loading control. Cell-membrane Isolation -Plasma membrane biotinylation was performed using Pierce EZ-Link Sulfo-NHS-SS-Biotin cell surface protein isolation kit according to manufacturer's instructions with slight modifications (SulfoLink; Cat. #89881, Pierce Biotechnology, Rockford, IL). Briefly, confluent rMTC cells were equilibrated with 0.5 mM Ca 2+ assay buffer for 5 hours and stimulated with 10 mM Ca2+ for 10 min. The cells were washed with PBS and incubated in the presence of Sulfo-NHS-SS-Biotin in HBSS at 4 0 C with gentle agitation.
After 30 min, the reaction was quenched, and the cells were harvested, lysed and subjected to a streptavidin-agarose column. Cytoplasmic proteins unexposed to the biotinylation reaction were isolated into the "flowthrough" fraction, and cell surface biotinylated proteins were eluted into the "eluate" fraction. The cytoplasmic and cell surface fractions were separated by SDS-PAGE and immunoblotted using various antibodies. Cell Adhesion Assay -96-well flat bottom plates coated with various concentrations of fibronectin (Sigma F1141) were washed and blocked with 2% filtered BSA solution for 1 hr at room temperature. rMTC cells were dissociated, washed, resuspended in assay buffer (serum free DMEM supplemented with 20 mM HEPES and 0.1% BSA, pH 7.4), and incubated at 37 0 C in a humidified 5% CO 2 incubator for 20 min to allow the cells to recover from the process of detachment. In parallel, the wells were aspirated, washed, and incubated with 50 μl of 2X DMSO, NPS R-568, or NPS 89636. For inhibition experiments, 50 μl of 2X NPS R-568 was incubated with 2X GRGDSP or 2X GRADSP peptides (EMD Biochemicals Inc.). 50 μl of cells diluted to 2.5 x 10 5 cells/ml were plated in triplicates and incubated at 37 0 C. After 1 h, the cells were washed three times with warm PBS supplemented with 0.2% BSA.
For each condition, input-control wells were maintained without washes. The cells were fixed with glutaraldehyde, stained with 0.1% crystal violent, and quantified by measuring the absorbance at 590 nM in a plate reader (Perkin Elmer). Absorbance readings from blank wells were used to subtract the background binding of crystal violet to plastic. Cell adhesion was quantified by representing the background subtracted absorbance readings as percentage of input. GraphPad Prism was used to plot the % input values and calculate the EC 50 and Hill slope values. All data represented correspond to means ± S.E.M. from representative experiments performed in triplicate.
Haptotaxis Cell Migration Assay -The lower surface of the transwell filters (8.0 μm pore size; #353097, BD Falcon) were coated with 10 μg/ml fibronectin overnight at 4 0 C. The filters were washed with PBS and the lower compartment was incubated with normal culture media in the presence of 1 μM NPS R-568 or DMSO control. 75,000 cells suspended in 200 μl of culture media were added to the upper chamber and incubated at 37 0 C for 20 h. For inhibition studies, both the upper and lower chambers were incubated with 500 μM GRADSP, 500 μM GRGDSP, or 1 μM NPS 89636. The cells were washed with PBS, fixed with glutaraldehyde and stained with 0.1% crystal violet for 1 h. The filters were washed and non-migratory cells on the upper-side of the filters were removed using cotton swabs. Cell migration was quantified by taking 8 random images per well using an inverted phase-contrast microscope (Nikon T100) attached with a Canon digital camera. Cells were counted and expressed as % control. Preparation of shRNA lentivral system and virus transduction -Short hairpin (sh) interfering RNA constructs were delivered into rMTC cells by lentiviral transductions. shRNAs directed at the β1 integrin were generated by cloning the following oligos into a second generation lentiviral packaging system (pLKO.1; Addgene) containing an IRES GFP sequence (generated in-house):
integrin shRNA #2 forward -5'CCGGGCACGATGTGATGATTTAGAACTC GAGTTCTAAATCATCACATCGTGCTTTTTG-3'; control scrambled shRNA sequence. Lentivirus was produced by transfecting 30-40% confluent monolayers of HEK293T cells in 10cm plates with VSV-G (4µg), psPAX2 (6 µg) and shRNAs cloned into pLKO.1-GFP vector (6µg) by calcium phosphate transfection method (26) . Media was changed 16 h post-transfection and virus subsequently collected after 24 and 48 h. Target cells were infected at 1:2 dilution of the virus in DMEM + 10% FBS media followed by media replacement after 24 h. Efficiency of viral infection was assessed by monitoring GFP expression (typically >90%) and knockdown of target protein was verified by western blot analysis. Data Analysis and Statistical Significance -Data are reported as means ± S.E.M. and analyzed by ttest or one-way ANOVA followed by Tukey's multiple comparison test. Statistical significance was accepted at p < 0.05 for all analyses. Concentration-response curves were generated by analyzing the data via a non-linear regression method (GraphPad Prism). Individual experiments were standardized by normalizing the data to the maximum and minimum values identified by the fitted curves. The normalized data from several experiments were used to generate the final concentration-response curves. Fig. 1) . These results demonstrated that the CaSR is functionally coupled to the Ca 2+ release pathway in rMTC 44-2 cells. The observation that the Hill coefficients for Ca 2+ and NPS 89636 are different than 1 is indicative of intrinsic receptor based cooperativity as seen in previous studies.
RESULTS

Functional Activity of the CaSR in rMTC 44
Identification of Integrins as CaSR Interacting
Proteins -To identify novel CaSR signaling partners, the endogenous CaSR expressed in rMTC cells was immunoprecipitated and subjected to LC-MS/MS analysis. Activation of the CaSR was required for efficient receptor solubilisation from rMTC cell membranes because solubilisation in buffer containing low Ca 2+ (1.5 mM which would induce little activation of the receptor), only low amounts of receptor were present in the solubilized fraction, whereas in solubilisation buffer containing high Ca 2+ (10 mM, sufficient for full activation, see Supplementary Fig. 1 ), the CaSR was highly concentrated in the solubilized fraction. The most prominent group of proteins identified in the LC-MS/MS analysis from the initial CaSR immuno-affinity pull-down experiments was the integrin family of ECM binding proteins. Members of the integrin family were among the most abundant proteins detected in terms of the total number of peptides identified, the percentage of sequence covered, and probabilities of identified peptides corresponding to the predicted proteins. Several isoforms of α and β integrins were identified in the LC-MS/MS analysis (see Supplementary Table 1 ). β1 integrin was selected for further evaluation because it forms obligate heterodimers with several α integrin subunits.
Co-immunoprecipitation experiments were carried out using the solubilized rMTC cell membrane fraction and three anti-CaSR antibodies (ADD, 4640, and 4641), targeting the CaSR extracellular domain, and two different β1-integrin antibodies targeting the C-terminus and Nterminus of β1 integrin. The ADD monoclonal antibody labelled a doublet on western blots; deglycosylation of the CaSR caused a shift in the relative molecular weight of the upper 130 kDa band to the lower 120 kDa band (Fig. 1A) . The β1 integrin N-terminal antibody immunoprecipitated the fully glycosylated form of the CaSR (M r = 130 kDa, Fig. 1B) . Conversely, both the CaSR ADD monoclonal antibody and the β1 integrin Nterminal antibody immunoprecipitated the immature 88 kDa form, and to a lesser extent, the mature 130 kDa glycosylated form of β1 integrin (Fig. 1C) .
To further substantiate this coimmunoprecipitation result, two additional CaSR antibodies (rabbit polyclonals 4640 and 4641) and a C-terminal β1 integrin antibody (Chemicon) were used. The two rabbit polyclonal antibodies strongly immunoprecipitated both the fully glycosylated and core glycosylated forms of the CaSR (Fig. 1D ), while immunoprecipitation with the CaSR ADD monoclonal antibody preferentially immunoprecipitated the fully glycosylated form (Fig. 1B) . The C-terminal β1 integrin antibody also immunoprecipitated the CaSR (Fig. 1D ) and immunoprecipitated the mature 130 kDa β1 integrin (Fig. 1E) , and in samples immunoprecipitated with the 4640 and the 4641 CaSR polyclonal antibodies, the mature 130 kDa form of β1 integrin was also detected when the blots were probed with the anti-β1 integrin antibody (Fig. 1E) .
To further validate the co-immunoprecipitation results, the rMTC cells were solubilized using more stringent conditions (compared with TX-100 only) with either 0.5% CHAPS or 0.5% deoxycholate + 0.1% SDS. Both conditions resulted in solubilisation of the CaSR and β1 integrins; more importantly, immunoprecipitation (using the 4641 anti-CaSR antibody) resulted in immunoprecipitation of the CaSR together with the β1 integrins (supplementary Fig. 2 ). Taken together, the co-immunoprecipitation results of multiple co-immunoprecipitation experiments demonstrated that the CaSR and β1 integrins are present together in a macromolecular complex in rMTC 44-2 cells.
Co-localization and Cell Surface Expression of
CaSR and β1-integrins -The cellular distributions of the CaSR and β1 integrins in rMTC 44-2 cells were assessed in immunolocalization experiments. Cells grown on poly-D-lysine treated glass coverslips in subthreshold Ca2+ levels (1.8 mM)
were fixed and incubated with a mouse anti-CaSR monoclonal antibody (ADD) targeting an extracellular epitope, and a rabbit anti-β1-integrin antibody (Abcam), and basolateral images were obtained using a confocal microscope. Although no permeabilization reagent was used, we found that fixation of the cells alone caused permeabilization (data not shown). The anti-CaSR antibody revealed an expression pattern of discrete punctate formations throughout the cells (Fig. 2A,  green) . Visible puncta of β1 integrin complexes were also abundantly expressed throughout the cell with a distribution similar to that seen with the CaSR (Fig. 2A, red) . In the merged images, the distribution of the CaSR overlapped extensively (but not completely) with that of β1 integrin ( Fig.  2A, yellow) . The co-localization was observed at all focal planes (basolateral and apical).
Although the co-localization images suggested that the CaSR and β1 integrins were codistributed, the membrane locations of the staining was unclear. Therefore, we evaluated cell surface expression of the CaSR and β1 integrins in the presence and absence of CaSR stimulation using a biotin-based cell surface protein isolation method in which biotin-labelled cell surface proteins were immobilised on agarose columns conjugated with streptavidin. To validate this method in rMTC cells, the cell surface expressed α3 subunit of Na + /K + -ATPase was used as a positive control for surface expression, while IP 3 receptor expression was used as a negative control to ensure intracellular specific expression,.
Using this method, the CaSR and β1 integrins were recovered in the cell surface fraction as identified by the presence of the α3 subunit of Na + /K + -ATPase, whereas IP 3 receptor was expressed exclusively in the intracellular fraction (Fig. 2B) . Some cell surface proteins were also detected at low levels in the intracellular fraction. However, the mature 130 kDa band of the CaSR appeared in the cell surface fraction, whereas the core glycosylated 120 kDa band appeared in the intracellular fraction (Fig. 2B) . Quantitation of the cell surface bands among 3 independent experiments reveal that the cell surface expression of the CaSR, β1 integrin and α3 ATPase were not affected by CaSR stimulation (10 mM Ca 2+ ; Fig. 2C ). Therefore, the biotin-streptavidin affinity chromatography analysis supported the [Ca 2+ ] i release and immunolocalization studies described above by establishing that both the CaSR and β1 integrins are expressed on the cell surface.
Potentiation of Fibronectin-mediated Cell
Adhesion by CaSR Positive Allosteric ModulatorEvidence from LC-MS/MS analysis, coimmunoprecipitation, and co-localization studies revealed that the CaSR and β1-containing integrins appeared to be components of a macromolecular protein complex.
β1-containing integrin heterodimers bind to the ECM protein fibronectin. Therefore, fibronectin-matrix based adhesion assays were conducted to determine the effects of CaSR stimulation on integrin-mediated cell adhesion. Since integrins are affected by changes in divalent cation concentration including Ca 2+ and Mg 2+ (31-33), we obviated the use of cations and instead used a CaSR-specific positive allosteric modulator (NPS R-568) in the presence of a submaximal concentration of extracellular Ca 2+ (1.8 mM). Fibronectin was coated onto 96 well plates at various concentrations (0 -15 µg/ml) and equal numbers of cells were then plated in the presence of 0.02% DMSO (vehicle control), 6 µM R-568 and/or 6 µM R-89636. Maximum cell adhesion levels were observed at fibronectin concentrations above 5 µg/ml. NPS R-568 potentiated the effects of fibronectin-mediated cell adhesion (Fig. 3A) ; compared to control, 6 µM R-568 significantly increased cell adhesion at fibronectin concentrations above 5 µg/ml, with the greatest impact observed at 7.5 µg/ml (166.1 ± 10.2% compared to control). Unlike NPS R-568, NPS 89636 alone had no significant effect on cell adhesion (Fig. 3A) .
The concentration dependence of R-568 stimulated cell adhesion was investigated at 1 and 2.5 µg/ml fibronectin, corresponding to the EC 20 and EC 40 values from fibronectin concentrationresponse experiments (Fig. 3B,C) . Under these conditions, R-568 stimulated cell adhesion in a concentration-dependent manner, with an EC 50 value of 111 ± 29 nM and Hill Slope of 1.9 ± 0.8 at 1 µg/ml fibronectin (Fig. 3B) and an EC 50 value of 38 ± 12 nM and Hill Slope of 1.6 ± 0.5 at 2.5 µg/ml fibronectin (Fig. 3C) .
Simultaneous addition of NPS R-568 and NPS 89636 abolished the effects of NPS R-568 alone (Fig. 3B, C) . The DMSO vehicle control did not promote cell adhesion at either 1 or 2.5 µg/ml fibronectin. Thus, the CaSR positive allosteric modulator NPS R-568 potently stimulated rMTC 44-2 cell adhesion in the presence of fibronectin.
Inhibition of NPS R-568-mediated Potentiation of
Cell Adhesion by GRGDSP Peptide -The GRGDSP peptide competes with fibronectin for integrin binding and serves as an inhibitor of integrin-mediated cell adhesion on RGDcontaining ECM proteins such as fibronectin (21) . To investigate whether the effects of R-568 on cell adhesion were dependent on integrin binding to the fibronectin-matrix, cell-adhesion was measured in the absence or presence of various concentrations of GRGDSP peptide and a single concentration of R-568 (300 nM); as above cells were plated on either 1 or 2.5 µg/ml of the fibronectin-matrix. A related peptide GRADSP, which exhibits markedly reduced peptide binding affinity (34, 35) was used as a negative control.
At 1 µg/ml fibronectin, GRGDSP at concentrations at and above 50 µM reduced the stimulatory effect of 300 nM R-568 on cell adhesion in a concentration-dependent manner (Fig. 4A) . The peptide induced a statistically significant decrease in cell adhesion at concentrations at and above 100 µM compared to the GRADSP control peptide. Thus, 100, 200, and 500 µM of GRGDSP suppressed cell adhesion by 70.1 ± 2.1%, 73.8 ± 4.8%, and 79.8 ± 1.3% compared to control no-peptide treatments (p < 0.05). At 2.5 µg/ml fibronectin, the GRGDSP peptide inhibited adhesion at concentrations above 100 µM with 500 µM GRGDSP inhibiting 300 nM R-568 mediated cell adhesion by 49.8 ± 6.3% (n = 4; p < 0.05, Fig. 4B ). Therefore, GRGDSP inhibited R-568-mediated potentiation of cell adhesion in a concentration-dependent manner. The results demonstrate that CaSR activation potentiates cell adhesion by promoting integrin binding to a fibronectin-rich matrix, at least in part by the RGD peptide sequence present in fibronectin.
R-568 Potentiates Fibronectin-mediated Cell
Migration via Integrin Activation -Human forms of medullary thyroid carcinoma are highly metastatic (36, 37) . The role of the CaSR-integrin protein complex in cell migration was further investigated in Boyden chamber experiments. rMTC cells did not exhibit chemotaxis in response to various stimuli, including fetal bovine serum, horse serum, or 1 µM R-568. However, rMTC cells displayed directional chemotaxis in response to the ECM protein fibronectin. rMTC cells migrated towards fibronectin-matrix treated filters whereas no migration was observed in bovine serum-treated filters and 1 µM R-568 significantly potentiated fibronectin-dependent cell migration by 218 ± 15% compared to a vehicle control (Fig.  5) . Furthermore, the potentiating effect of 1 µM R-568 on cell migration was eliminated by 500 µM GRGDSP peptide or 1 µM of the CaSR antagonist NPS 89636, with 98 ± 17% and 77 ± 15% cell migration respectively (P < 0.005). NPS 89636 (1 µM) had no effect on cell migration in the absence of R-568 and the negative control peptide GRADSP did not reverse the positive effect of 1 µM R-568 (Fig. 5) .
To further validate the role of β1 integrins in R-568 mediated potentiation of cell adhesion and migration, protein expression levels of β1 integrin in rMTC cells were knock-downed by an shRNAlentiviral based system. Robust protein knock down was observed using β1 integrin shRNA sequence #2, whereas shRNA sequence #1 showed β1 integrin expression similar to that of the control shRNA (scrambled) condition (Fig. 6A) . β1 integrin shRNA #2 inhibited R-568 stimulated cell adhesion and migration on fibronectin, while scrambled and shRNA #1 treatment did not inhibit CaSR mediated cell adhesion and migration (Fig.  6B, C) . These data further demonstrate that CaSR-stimulated cell migration towards a fibronectin matrix is mediated by β1 integrins.
The Effects of Intracellular Signaling Inhibitors on
CaSR-mediated Cell Adhesion and MigrationCaSR enhancement of cell adhesion and migration could occur through CaSR mediated intracellular second messenger signalling mechanisms. The CaSR couples to several G-protein-dependent signalling systems such as Gq-mediated activation of PLC and Ca 2+ i release, G i -mediated reduction in cyclic AMP production, G 12/13 induced Rho kinase activation, as well as phosphorylation of MAPK/ERK (1, 27, (38) (39) (40) . These intracellular signalling mechanisms could induce inside-out signalling via an integrin-associated protein to facilitate the binding of integrins to ECM proteins.
To investigate potential biochemical pathways involved in CaSR-mediated cell adhesion and migration, inhibitors of intracellular signalling pathways were tested. It was anticipated that inhibition of the signalling pathway(s) involved in the CaSR-mediated effects would reduce or block CaSR promotion of cell adhesion and migration. Inhibition of G αi , PKC, and voltage-gated calcium channels using pertussis toxin (100 and 200 ng/ml), chelerythrine (5 µM), and verapamil (100 µM) respectively did not significantly affect NPS R-568 potentiation of cell adhesion or migration (Supplementary Fig. 3 ). In contrast, inhibition of PLC, ERK, and Rho-associated kinase (ROCK) affected CaSR-mediated adhesion and/or migration. The PLC inhibitor U73122 had no significant effect at 1 µM but significantly reduced NPS R-568 stimulation of [Ca 2+ ] i release, and blocked both NPS R-568 potentiated cell adhesion and migration at 3 µM (Fig. 7A-C) . Similarly, chelation of [Ca 2+ ] i with BAPTA-AM significantly reduced the NPS R-568-induced rise in [Ca 2+ ] i and blocked NPS R-568 potentiation of cell adhesion and migration (Fig. 7D-F) .
Inhibition of ERK using PD98059 (30 µM) reduced ERK activation (Fig. 7G ) but had no effect on basal or NPS R-568 stimulated cell adhesion (Fig. 7H) . The ROCK inhibitor Y27632 (30 µM) also had no effect on NPS R-568-mediated cell adhesion (Fig. 7J) . Surprisingly, PD 98059 and Y27632 strongly potentiated the positive effect of NPS R-568 potentiation on cell migration (Fig. 7I, K) .
In summary, the results of the signal transduction analyses indicated that CaSR stimulation of PLC and the subsequent rise in [Ca 2+ ] i is required for the positive CaSR effects on cell adhesion and migration.
DISCUSSION
Cell adhesion and migration are crucial events during organogenesis and abnormalities in cell movement and adhesion play an essential role in tumour growth and cancer cell metastasis. Recent studies have implicated the CaSR in the regulation of cell migration in the developing nervous system and in cancer metastasis (9, 15) .
Here, we identified the integrins as key protein interaction partners with the functionally active CaSR endogenously expressed in rat medullary thyroid carcinoma cells.
The integrins are obligate heterodimers composed of α and β subunits. In mammals, there are 18 α and 8 β integrin subunits that can form 24 functional heterodimers with distinct distributions, ligand preferences, and signal transduction mechanisms (20) . Integrins control cell function by binding to ECM proteins to transduce information from the ECM to adjacent cells, as well as conveying intracellular signals from within cells to the extracellular environment via conferring changes in affinity for ECM proteins. Thus, the integrins display bidirectional signalling and directly participate in various cellular activities involved in cell adhesion and movement (41) .
The identification of the integrins as CaSR interacting proteins was initially determined from CaSR immuno-affinity pull-down experiments in rMTC 44-2 cells (Fig. 1) . Further confirmation of the CaSR-integrin interaction was provided by extensive co-immunoprecipitation experiments and cellular co-localization analysis. Pharmacological stimulation of the CaSR using the positive allosteric modulator NPS R-568 potently enhanced cell adhesion and migration. Evidence that these effects occurred via the integrins was provided by the demonstration that the enhancement of cell-ECM adhesion by NPS R-568 could be largely blocked by the addition of GRGDSP integrin blocking peptide, but not by a control peptide (GRADSP) that does not compete with fibronectin for β1-integrin binding. Further confirmation of the role of integrins was obtained in knock down experiments where shRNAmediated knock down of β1-containing integrins reduced CaSR-mediated cell adhesion and migration.
We conclude that the CaSR is associated with β1-containing integrins in a macromolecular protein complex and that stimulation of the CaSR promotes cell adhesion and migration via integrin activation.
At the molecular level, potential mechanisms for functional cooperation between the CaSR and integrins include an interaction between the CaSR homodimer and the integrin heterodimers as part of a protein-protein tetramer, or alternatively, in an interaction where the GPCR and integrin are functionally associated indirectly as part of a macromolecular complex containing additional proteins.
A calcium-induced conformational change may be followed by a second stage that involves the activation of second messengermediated pathways. We propose a model whereby an agonist-induced conformational change in the CaSR induces a shift of the integrin heterodimer into an active conformation (Fig. 8) . Both classes of proteins possess large extracellular domains and although no direct studies examining conformation changes in the CaSR have been reported, other class C GPCRs such as the GABA B and the metabotropic glutamate receptors are known to undergo closure of their extracellular Venus flytrap domains upon agonist binding (42) (43) (44) . A Ca 2+ -induced stimulation of the CaSR that drives integrins into the active conformation could promote binding to ECM proteins, thereby transmitting conformational changes to other downstream proteins and adjacent cells. Phosphorylation of focal adhesion kinase and subsequent activation of Src kinase is one such pathway by which integrins mediate outside-in signalling (45, 46) .
These kinases form the backbone of the adhesion and migration complex, and the observation that CaSR can activate Src (47) suggests a possible link between this tyrosine kinase, the CaSR, and integrins in the context of cell adherence.
The results of experiments using inhibitors of intracellular signalling systems demonstrated that activation of PLC participates in CaSR-mediated cell adhesion and migration (Fig. 7, 8 (50, 51) , and this appears to be linked to Ca 2+ -dependent cell detachment mechanisms such as increased contractility, enzymatic adhesion disassembly or increased actin severing to the rear (49, 52, 53 Despite strong evidence for the role of the G q /PLC/Ca 2+ pathway described above, we cannot rule out the possibility that the effects may also involve G 12/13 (and p115 or other Rho-GEFmediated signaling). Due to the inability to transfect the rMTC-44-2 cells, we were not able to test the effects of inhibitory dominant negative cDNA constructs G 12/13 or Rho-GEF in this system (unpublished observation).
In addition to the G q /PLC/IP 3 pathway, we also investigated the ERK and ROCK signaling pathways. In contrast to inhibitors of intracellular calcium release which reduced or blocked NPS R-568-mediated adhesion and migration, the ERK and ROCK inhibitors had no effect on rMTC-44-2 cell adhesion but potentiated the R-568 enhancement of migration.
Previous studies examining the effects of ERK and ROCK inhibitors on cell migration have shown variable effects on cell migration. For example, in vitro and in vivo experiments on breast cancer tissues or cell lines showed that Y27632 inhibited cell migration and metastasis (55) , while other studies such as those conducted on trophoblast cells (56) have shown a potentiating effect, as shown here. There is evidence that the effects of ROCK depend on the mode of cell migration (e.g. "rounded" vs. "elongated protrusion" modes of cell motility) in different cell types (57) .
Our results with the ERK and ROCK inhibitors were unexpected and differ from some previous reports of the effects of ERK or ROCK on cell migration (58) (59) (60) . The effect of ROCK inhibition might be due to the fact that ROCK phosphorylates and inactivates myosin phosphatase preventing myosin light chain phosphorylation and subsequent cell outgrowth. Inhibition of Rho kinase (ROCK) increases neurite outgrowth by preventing the activity of myosin light chain, therefore obstructing F-actin stabilization and actin-myosin cross-linking (61, 62) . Thus destabilization of F-actin promotes stress fiber formation and may have caused increased cell migration in our experiments. In the case of ERK, it has been shown that filamin A binding to the C-terminus of the CaSR stabilizes the receptor and attenuates its degradation rate, thereby facilitating MAPK/ERK signaling (63 The rMTC 44-2 cell line was derived from a rat medullary thyroid carcinoma originating from the calcitonin expressing thyroid C-cells (64, 65) . Our results demonstrate that rMTC 44-2 cells express high levels of the CaSR.
Human C-cell carcinomas are metastatic and often colonize bone tissue, an environment enriched in extracellular Ca 2+ at levels sufficient to significantly or fully activate the CaSR. The mechanism of medullary thyroid carcinoma metastasis to bone has never been identified despite clinical data indicating that distant metastasis is observed in 7 -23 % of patients with MTC, and is a major cause of MTCrelated deaths with survival rates of 25% at 5 years after detection, and 10% at 10 years (36, 66) . Our findings suggest that the CaSR may participate in medullary thyroid carcinoma bone metastasis by activation of a CaSR-integrin signalling complex that becomes preferentially activated in the high Ca 2+ environment of bone and thereby promoting cellular adhesion of the tumour cells within bone. Breast and prostate tumour cells also metastasize to bone; 65 -75% of advanced breast and prostate cancer patients have secondary tumours in bone, with a 5 year survival rate of only 20 -25% (67) . Interestingly, the CaSR has been shown to enhance the metastatic potential in various bonepreferring breast and prostate cancer cell lines (15, 16, 68) . For example, in vitro experiments have revealed that blocking CaSR function in PC3 prostate cancer cells and MDA-MB-231 breast cancer cells inhibits cell adhesion and migration (15, 16) . Therefore, the key features of the CaSRintegrin complex identified in the current study in medullary thyroid carcinoma cells might be applicable to other cancer cell types that robustly express the CaSR and that metastasize to bone. 2+ were immunolabelled with extracellular epitope mouse ADD anti-CaSR antibody (1:500) and a rabbit anti-β1-integrin antibody (1:400), and viewed using a confocal microscope (100X). CaSR expression was present in discrete puncta distributed throughout the cell (green). β1-integrin was also expressed throughout the cell (red) and showed extensive overlap with the CaSR expression (yellow). Photomicrographs are representative of similar results obtained in three experiments. (B) Cells were preincubated with 0.5 mM Ca 2+ for 5 h prior to addition of buffer (control) or 10 mM Ca 2+ for 10 min. and cell surface proteins were covalently biotinylated and subjected to streptavidin-agarose chromatography. Cytoplasmic proteins appeared in the "Flow Through" fraction whereas cell surface proteins were eluted in the "Eluate". The CaSR, β1-integrin and α3 subunit of the Na+/K+-ATPase (plasma membrane marker) were found in the cell surface fraction, whereas IP 3 receptor (intracellular membrane marker) was found in the intracellular fractions. The CaSR immunoblot analysis (using the ADD monoclonal antibody) showed that the 130 kDa mature form of the CaSR was recovered primarily in the cell surface fraction as expected, whereas the 120 kDa immature form was recovered in the 'flow-through' (N = 3). (C) Band intensities present in the eluted fractions of the CaSR, β1 integrin and α3 subunit blots were analyzed and are presented as a percent of control (N = 3). FIGURE 3. The CaSR positive allosteric modulator NPS R-568 potentiated fibronectin mediated cell adhesion. (A), rMTC 44-2 cells were incubated on fibronectin-coated wells (0 -15 μg/ml) in the absence or presence of 0.02% DMSO (control), 6 μM NPS R-568 or 6 μM NPS 89636. Treatment of rMTC 44-2 cells with 6 μM NPS R-568 significantly increased cell adhesion over control levels, whereas 6 μM of the CaSR antagonist NPS 89636 did not significantly affect cell adhesion. Each condition from individual experiments was performed in triplicate and expressed as a percentage of "input", which represents control wells that were not subjected to washes. Data points were normalized to maximal cell adhesion level obtained under the control condition (i.e. in the absence of R-568 or 89636) (N = 5). *, p<0.05. (B), NPS R-568 increased cell adhesion in a concentration-dependent manner. rMTC 44-2 cells were incubated on 1 μg/ml fibronectin in the presence of various concentrations of NPS R-568 (1 nM to 10 μM) or DMSO control (3x10 -6 -3x10 -3 %). The data points (mean ± S.E.M..) were normalized by standardizing basal cell adhesion levels to 0% and maximal adhesion levels to 100% by analyzing the NPS R-568 treated data using GraphPad software. At 1 μg/ml fibronectin, NPS R-568 stimulated cell adhesion in a dose-dependent manner with an EC 50 = 111 ± 29 nM and Hill slope = 1.9 ± 0.8 (N = 7). (C), At 2.5 μg/ml fibronectin, NPS R-568 displayed a more potent dose-dependent stimulation on cell together with increased [Ca 2+ ] i from G αq activation of PLC and the IP 3 receptor, could induce the integrin to flip it into an activate state promoting binding to the ECM resulting in enhanced cell adhesion and migration. The "X" in the right hand panel denotes a hypothetical protein that may participate in facilitating the CaSR-mediated activation of integrins subsequent to increased [Ca 2+ ] I .
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